Krister Wennerberg

Krister Wennerberg is a Professor at the University of Copenhagen, affiliated with the Biotech Research & Innovation Centre (BRIC) within the Faculty of Health and Medical Sciences. His research group, the Wennerberg Group, focuses on advancing cancer therapeutics through computational and experimental approaches.

Wennerberg's research interests span cancer biology, particularly leukemia, with expertise in drug discovery, computational biology, and precision medicine. His work investigates synthetic lethality, cancer signaling pathways (particularly KRAS and ERK), and the development of novel therapeutic strategies for hematological malignancies. His approach combines high-throughput screening, machine learning, and molecular biology to identify effective drug combinations and repurposing opportunities.

His publications demonstrate significant contributions to understanding drug resistance mechanisms in acute myeloid leukemia, development of microenvironment models for leukemia studies, and identification of novel therapeutic targets in cancer. His research has been published in high-impact journals including Science, Nature Reviews Drug Discovery, and Blood, reflecting the translational significance of his work.

Wennerberg maintains extensive collaborative networks across Scandinavia and internationally, as evidenced by his co-authorships on numerous publications with researchers from multiple institutions. His work receives attention across academic and clinical communities, with mentions in peer review sites, news outlets, and social media platforms.